4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-018775
Chief Executive Officer acquired 84,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2024-05-28 | Option exercise | +84,000 | $0.00 | $84 | 250,130.8 | D |
| Derivatives | |||||||
| Robinson Chandler Chief Executive Officer | 2024-05-28 | Option exercise · Stock Options | −84,000 | 0 | D | ||
Loading xslF345X05/rdgdoc.xml…